Back
ESC Premium Access

Cardiovascular toxicity of ibrutinib: a pharmacovigilance study.

Session: Poster Session 2 - Use benefit and risk of pharmacotherapy
Topic: Cardiotoxicity of Drugs
Speaker: Doctor J. Salem (Paris, FR)
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

About the speaker

Doctor Joe Elie Salem

Sorbonne University, Paris (France)
2 presentations
0 follower

6 more presentations in this session

Research network in Africa (RNA) : antihypertensive drugs strategies in 12 African countries

Speaker: Professor A. Kane (Saint-Louis, SN)

Access
Abstract
Slides
Like
Thumbnail

Comparison of effects of lowering blood pressure in individuals with blood pressure <140/90 mmHg and hypertension guideline recommendations: a systematic review and meta-analysis of randomised trials

Speaker: Doctor A. Mohammad (Hyderabad, IN)

Access
Abstract
Like
Thumbnail

Beta-blocker therapy and risk of dementia: a population-based prospective study

Speaker: Doctor H. Holm (Malmo, SE)

Access
Abstract
Like
Thumbnail

Thiazides and skin cancer risk: should we be worried?

Speaker: Doctor J. Sousa (Porto, PT)

Access
Abstract
Slides
Like
Thumbnail

Amlodipine induces vasodilation via Akt2/Sp1-activated miR-21 in smooth muscle cells

Speaker: Associate Professor C. Chen (Wuhan, CN)

Access
Like
Thumbnail

Access the full session

Poster Session 2 - Use benefit and risk of pharmacotherapy

Speakers: Doctor J. Salem, Professor A. Kane, Doctor A. Mohammad, Doctor H. Holm, Doctor J. Sousa...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources